
USD
$0.00
(0.00%
)At Close (As of Nov 5, 2025)
$138.67B
Market Cap
47.15
P/E Ratio
7.69
EPS
$403.95
52 Week High
$327.71
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $14B |
| Total Revenue | $23B |
| Cost Of Revenue | $8.6B |
| Costof Goods And Services Sold | $8.6B |
| Operating Income | $5.1B |
| Selling General And Administrative | $7.7B |
| Research And Development | $1.4B |
| Operating Expenses | $8.9B |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | $257M |
| Interest Expense | $396M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.1B |
| Income Before Tax | $3.5B |
| Income Tax Expense | $499M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $3B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $3.9B |
| Ebitda | $4.9B |
| Net Income | $3B |
| Field | Value (USD) |
|---|---|
| Total Assets | $43B |
| Total Current Assets | $15B |
| Cash And Cash Equivalents At Carrying Value | $3.7B |
| Cash And Short Term Investments | $3.7B |
| Inventory | $4.8B |
| Current Net Receivables | $4B |
| Total Non Current Assets | $28B |
| Property Plant Equipment | $4B |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $4.4B |
| Intangible Assets Excluding Goodwill | $4.4B |
| Goodwill | $16B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $750M |
| Other Current Assets | $1.7B |
| Other Non Current Assets | - |
| Total Liabilities | $22B |
| Total Current Liabilities | $7.6B |
| Current Accounts Payable | $1.7B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.4B |
| Total Non Current Liabilities | $15B |
| Capital Lease Obligations | - |
| Long Term Debt | $12B |
| Current Long Term Debt | $1.4B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.4B |
| Other Current Liabilities | $4B |
| Other Non Current Liabilities | $2.2B |
| Total Shareholder Equity | $21B |
| Treasury Stock | - |
| Retained Earnings | $19B |
| Common Stock | $38M |
| Common Stock Shares Outstanding | $386M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $4.2B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.1B |
| Capital Expenditures | $755M |
| Change In Receivables | - |
| Change In Inventory | -$206M |
| Profit Loss | - |
| Cashflow From Investment | -$3B |
| Cashflow From Financing | -$525M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $1.2B |
| Dividend Payout Common Stock | $1.2B |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$195M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $3B |
| Field | Value (USD) |
|---|---|
| Gross Profit | $14B |
| Total Revenue | $23B |
| Cost Of Revenue | $8.6B |
| Costof Goods And Services Sold | $8.6B |
| Operating Income | $5.1B |
| Selling General And Administrative | $7.7B |
| Research And Development | $1.4B |
| Operating Expenses | $8.9B |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | $257M |
| Interest Expense | $396M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.1B |
| Income Before Tax | $3.5B |
| Income Tax Expense | $499M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $3B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $3.9B |
| Ebitda | $4.9B |
| Net Income | $3B |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-09-30 |
| Declaration Date | 2025-08-07 |
| Record Date | 2025-09-30 |
| Payment Date | 2025-10-31 |
| Amount | 0.84 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Stryker Corporation is a leading global medical technology company headquartered in Kalamazoo, Michigan, renowned for its innovative solutions in the healthcare sector. The company specializes in a diverse range of products, including joint replacement implants, surgical equipment, and advanced navigation systems, as well as patient handling and emergency medical devices. With a strong commitment to enhancing patient care across multiple specialties such as orthopedics, neurosurgery, and emergency medicine, Stryker leverages cutting-edge technology to improve surgical outcomes and streamline healthcare processes. Its robust portfolio positions Stryker as a key player in the rapidly evolving medical device industry, making it an attractive investment opportunity for institutional investors.